SCHEMBL20176153

SCHEMBL20176153

CC(C)c1cc(Cl)ccc1-n1cnc(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
KCNH2 Q12809 1/20 0.34
F11 P03951 7/20 0.34
KLKB1 P03952 7/20 0.34
IDH1 O75874 1/20 0.33
PTGER1 P34995 1/20 0.32
CNR1 P21554 1/20 0.32
FABP4 P15090 1/20 0.32
GCGR P47871 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
HTT P42858 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PSEN1 P49768 2/20 0.31
PSEN2 P49810 2/20 0.31
APH1B Q8WW43 2/20 0.31
NCSTN Q92542 2/20 0.31
APH1A Q96BI3 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17661858 0.86 IDH1 (0.43) IDH1PSEN1PSEN2APH1BNCSTN
SCHEMBL19412448 0.82 F11 (0.37) GABRA1GABRB1KCNH2F11KLKB1
SCHEMBL19412447 0.82 KCNH2 (0.33) GABRA1GABRB1KCNH2F11KLKB1
SCHEMBL17661899 0.81 PDE3B (0.38) KCNH2F11KLKB1IDH1HTT
SCHEMBL17661862 0.81 CNR1 (0.32) GABRA1GABRB1KCNH2IDH1CNR1
SCHEMBL17661859 0.81 P4HTM (0.36) GABRA1GABRB1KCNH2IDH1
SCHEMBL20176168 0.80 KDM4E (0.42) PTGER1LMNA
SCHEMBL18330391 0.79 MAPK14 (0.40) F11KLKB1LMNAPSEN1PSEN2
SCHEMBL20359777 0.76 ALDH1A1 (0.35) F11KLKB1LMNAHTTPSEN1
SCHEMBL30702162 0.76 ALDH1A1 (0.35) F11KLKB1LMNAHTTPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10676477-B2 Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group BRISTOL-MYERS SQUIBB COMPANY (US) 2020-06-09 US disclosed
US-10287288-B2 Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties BRISTOL-MYERS SQUIBB (US) 2019-05-14 US disclosed
US-20180215755-A1 FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES BRISTOL MYERS SQUIBB CO (US) 2018-08-02 US disclosed
US-20180215755-A1 FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES BRISTOL MYERS SQUIBB CO (US) 2018-08-02 US disclosed
US-20180162821-A1 FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS BRISTOL-MYERS SQUIBB COMPANY 2018-06-14 US disclosed
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F11 GABRA1 4037/4885GABRB1 4284/4885KCNH2 1610/4885
US-20180215755-A1 FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES TFPI, TFPI2, F11 GABRA1 3703/4885GABRB1 4047/4885KCNH2 1338/4885
US-20180162821-A1 FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS F11, F12, TFPI GABRA1 3865/4885GABRB1 4533/4885KCNH2 2434/4885
US-10676477-B2 Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group TFPI, TFPI2, F2 GABRA1 4241/4885GABRB1 4473/4885KCNH2 1684/4885
US-10287288-B2 Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties TFPI, TFPI2, F11 GABRA1 3703/4885GABRB1 4047/4885KCNH2 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.